MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
Calvary Mater Newcastle Hospital
Waratah, AustraliaCalvary Mater Newcastle Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
The Lancet, Vol. 393, Núm. 10168, pp. 229-240